Publication | Closed Access

High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicity

Hematological MalignancyHigh-dose CyclophosphamideMedicinePharmacologyImmunologyHematologyMyeloid NeoplasiaMultiple MyelomaPharmacotherapyOncologyRadiation OncologyHealth Sciences